CAR T-cell therapy

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  

CAR T-cell therapy
Mar 21, 2025, 18:33 | Science
Yan Leyfman: Researchers have shed light on a critical aspect of CAR-T therapy - long-term complications
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn about…
Mar 21, 2025, 12:00 | Dialogues
Episode 2 with Ziad Abuhelwa – Cancer Through My Eyes
We are excited to bring you the second episode of Cancer Through My Eyes, our…
Mar 14, 2025, 14:58 | Science
Yan Leyfman: Advancing CAR Therapy for AML
Yan Leyfman, Co-founder and executive director of MedNews Week, shared an article by Sascha Haubner,…
Mar 11, 2025, 09:47 | Science
Sandra McGuigan: An extraordinary 18 years of remission from neuroblastoma due to CAR-T cell therapy
Sandra McGuigan, Oncology Therapy Lead at Fortrea, shared a post on LinkedIn about a paper…
Mar 7, 2025, 09:21 | Stories
Young Cancer Survivor’s Resilient Journey
Eugene A. Woods, Chief Executive Officer at Advocate Health, posted on LinkedIn: "When people ask…
Mar 7, 2025, 01:18 | Immune Oncology
Immunotherapy for Brain Cancer: Types, Success Rate, Side Effects and More
Brain cancer, particularly aggressive forms like glioblastoma, remains one of the most challenging malignancies to…
Mar 5, 2025, 16:04 | Science
Yan Leyfman: Advancing CAR T-Cell Therapy - Faster and Effective for Lymphoma Patients
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn about…
Mar 3, 2025, 12:37 | Blog
Expanding CAR-T Therapy Access: A Collaboration between Boston and Cairo - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "In the U.S., CAR-T cell therapy has…
Feb 26, 2025, 10:09 | Blog
No evidence to suggest that CAR T cell therapy leads to secondary cancers
Cancer Research Institute posted on LinkedIn. "A study of over 700 patients treated with CAR…
Feb 25, 2025, 08:29 | Science
Maximilian Merz: What is the biology behind CAR+ T-cell lymphomas?
Maximilian Merz, Head of Early Clinical Trials Unit Leipzig (ECTUL) at Leipzig University, shared an…
Feb 22, 2025, 15:04 | Blog
John Gordon: Successful CAR Tcell Therapy - "It's a Bug's Life"
John Gordon, Co-Founder, Director and VP of Scientific Affairs at Celentyx, posted on LinkedIn about…
Feb 22, 2025, 14:10 | Science
Yan Leyfman: Advancing CAR T-Cell Therapy - Off-the-Shelf Allogeneic Approach
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn about…
Feb 20, 2025, 09:09 | Science
Yan Leyfman: New Insights in CAR T-Cell Therapy for Multiple Myeloma
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn about…
Feb 15, 2025, 02:25 | Immune Oncology
Immunotherapy for Lymphoma: Types, Success Rate, Side Effects and More
Immunotherapy has revolutionized lymphoma treatment, offering new hope to patients by harnessing the immune system…
Feb 3, 2025, 15:25 | Science
Hung Trinh: Making Strides Toward Off-the-Shelf CAR T Cell Therapy for Cancer
Hung Trinh, CMC/MFG Consultant and Managing Director at Vertex Biopharm Consulting, shared on LinkedIn: Making Strides…
Feb 3, 2025, 14:13 | Blog
David Barbie and his research team have been awarded the inaugural IASLC and LCRF Team Science Research Grant
Dana-Farber Cancer Institute posted on LinkedIn: "David Barbie, MD, and his research team have been…
Feb 3, 2025, 10:33 | Science
A novel CAR T cell therapy for people with large B-cell lymphoma by Jae Park et al. - MSK Department of Medicine
MSK Department of Medicine shared a post on X about a recent paper by Jae…
Jan 28, 2025, 20:25 | Blog
Hung Trinh: Direct in vivo CAR T cell engineering
Hung Trinh, CMC/MFG Consultant and Managing Director at Vertex Biopharm Consulting, posted on LinkedIn about…
Jan 24, 2025, 17:13 | Blog
Shernan Holtan: Are we facing a mentorship gap in training the next generation to diagnose and manage chronic GVHD?
Shernan Holtan, Chief of Blood and Marrow Transplantation and Professor of Medicine at Roswell Park…
Jan 23, 2025, 21:19 | Blog
Boris Pasche: A Memorable Day for Karmanos Cancer Institute
Boris Pasche, President and CEO of the Karmanos Cancer Institute, shared a post by Karmanos…
Jan 23, 2025, 12:47 | Insight
Amol Akhade: CAR-T Data for CRC in ASCO 24
Amol Akhade, Consultant Medical Oncologist and Hemato-oncologist at Suyog Cancer Clinics, shared a post on…
Jan 22, 2025, 15:04 | Science
Elias Orouji: CAR-T Cell Therapy for Colorectal Cancer
Elias Orouji, Principal Investigator of Scientific Advisor at University Health Network, shared a recent article…
Jan 15, 2025, 17:14 | Insight
Elias Orouji: A comprehensive review of the application of CAR-T cell therapy in colorectal cancer
Elias Orouji, Epigenomics Lead at Princess Margaret Genomics Centre, shared a post X about a…
Jan 14, 2025, 19:05 | Science
Shaida Ouladan: Chimeric Antigen Receptor-T Cells in Colorectal Cancer
Shaida Ouladan, a Molecular Pathology Scientist, shared a recent article on LinkedIn: "I’m thrilled to…
Jan 14, 2025, 15:01 | Career
OncoInfluencers to Follow on Social Media: Nico Gagelmann
We’re excited to feature Nico Gagelmann, a distinguished physician and scientist, as our next oncoinfluencer.…
Jan 13, 2025, 15:28 | Insight
CAR-T cell therapy for breast cancer: Current status and future perspective
A recent paper by Giuseppe Buono, Medical Doctor at IRCCS National Cancer Institute "Fondazione G.…
Jan 10, 2025, 06:42 | Science
Samer Al Hadidi: Safety and efficacy of CAR-T cell therapy in patients with autoimmune diseases
Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, posted on X about recent paper…
Jan 8, 2025, 12:34 | Insight
Hung Trinh: Researchers have re-engineered immune cells that penetrate and kill solid tumors
Hung Trinh, Senior Director of Business Development at OBiO Tech, shared a post on LinkedIn:…
Jan 6, 2025, 14:52 | Blog
E.Senthil Kumar: From Shadows to Solutions - The Revolution Against Cancer
E.Senthil Kumar, Medical Oncologist at Red Hills, Chennai, shared a post on X: "From Shadows…
Dec 29, 2024, 16:39 | Science
Myeloma Paper of the Day, December 29th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: BCMA-directed CAR T-cell therapy…
Dec 28, 2024, 14:09 | Science
The new NCCN guidelines for immunotherapy-related toxicities
Elvina Almuradova, Associate Professor and Medical Oncologist Ambassador at European School of Oncology, shared a…
Dec 27, 2024, 17:35 | Blog
Rahul Gosain: CLL Highlights with John Allan
Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared a…
Dec 23, 2024, 21:16 | Insight
Hung Trinh: CAR-T cell therapy for the treatment of adult high-grade gliomas
Hung Trinh, Senior Director of Business Development at OBiO Tech, shared a post on LinkedIn:…
Dec 16, 2024, 13:20 | Blog,Science
Predicting the effectiveness of CAR T-cell therapy in children with leukemia (B-ALL) - The Princess Máxima Center for Pediatric Oncology
The Princess Máxima Center for Pediatric Oncology posted on LinkedIn: "Two new studies start thanks…
Dec 15, 2024, 18:38 | Science
Ahmed Kotb: Infection risk in CAR T-cell therapy
Ahmed Kotb, Hematologist and Bone marrow transplanter at King Faisal Specialist Hospital International Holding Company…
Dec 12, 2024, 16:30 | Insight
Miguel Bronchud about long term toxicities of CAR-T
Miguel Bronchud, Co-Founder and Advisory Board at Regenerative Medicine Solutions, shared a post on LinkedIn:…
Nov 21, 2024, 09:55 | Blog
New Hope for Mantle Cell Lymphoma Patients - The Babak Lab
The Babak Lab shared a post on LinkedIn: “FDA Approval Alert: New Hope for Mantle…
Nov 17, 2024, 18:26 | Opinion
Patrick Hwu: How can we enhance CAR-T cell activity against solid cancers?
Patrick Hwu, President and CEO of Moffitt Cancer Center, shared a post on X: "How can we enhance…
Nov 16, 2024, 16:02 | Insight
Shahrin Ahmed: CAR-T cells as a new treatment for Glioblastoma
Shahrin Ahmed, Medical specialist in oncology at the Canadian Cancer Society, shared a post on…
Nov 16, 2024, 15:48 | Blog
Could CAR T-cell therapy show promise against deadly childhood brain cancer - Cancer Research Institute
Cancer Research Institute (CRI) shared a post on LinkedIn: "Could CAR T-cell therapy show promise…
Nov 10, 2024, 12:56 | Blog
Interius BioTherapeutics Doses First Patient with in vivo CAR Gene Therapy for B-cell Malignancies
INT2104 is a novel in vivo chimeric antigen receptor (CAR) gene therapy designed to generate…
Nov 10, 2024, 04:17 | Blog
M. Bilal Abid: Reporting data on the efficacy and safety of bispecific CAR T-cell therapy in hematological malignancies
M. Bilal Abid, Research Fellow in Cancer Therapeutics at MD Anderson Cancer Center, shared on…
Nov 9, 2024, 12:04 | Insight
Celebrating 40 Years of TCR Discovery: A Gathering of Giants in T Cell Immunology
This year marks the 40th anniversary of the discovery of the T cell receptor (TCR),…
Nov 8, 2024, 14:11 | Blog
Atrium Health Opens State-of-the-Art Outpatient Transplant and Cellular Therapy Unit
Atrium Health recently celebrated the opening of the Levine Cancer Institute’s Outpatient Transplant and Cellular…
Nov 7, 2024, 13:07 | Blog
Francisco Conesa Buendía: Advancing CAR-T Cell Therapy for Solid Tumors
Francisco Conesa Buendía, Assistant of Cell and Gene Therapies Manufacturing at Memorial Sloan Kettering Cancer…
Nov 6, 2024, 12:01 | Insight
John Gordon: Dual “ON/OFF”-switch CARs offer a safer CAR T cell therapy
John Gordon, Vice president of Scientific Affairs at Celentyx Ltd, shared a post on LinkedIn: “Dual ‘ON/OFF’-switch CARs…
Nov 4, 2024, 15:55 | Insight
Yan Leyfman: An innovative approach to promote CAR T cell longevity and boost therapeutic efficacy
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn by Francisco…
Oct 30, 2024, 13:33 | Blog
Francisco Conesa Buendía: How CRISPR is shaping the future of CAR T-cell therapy
Francisco Conesa Buendía, Cell and Gene Therapies Manufacturing Assistant at Memorial Sloan Kettering Cancer Center,…
Oct 25, 2024, 09:34 | Blog
EHA-EBMT 7th European CAR T-cell Meeting
EHA-EBMT 7th European CAR T-cell Meeting will be held from 6 February 2025 - 8 February 2025,…
Oct 14, 2024, 18:16 | Blog
Yan Leyfman: An innovative approach to challenges of CAR T cell therapy
Yan Leyfman shared a post by Christine H., Director, Gilead Sciences, on LinkedIn, adding: "An innovative approach…
Oct 11, 2024, 15:13 | Insight
Aggressive Lymphoma after CD19 CAR T-Cell Therapy suggested by Vivek Subbiah
Vivek Subbiah shared a post on X: "Aggressive Lymphoma after CD19 CAR T-Cell Therapy clonal hematopoiesis…
Oct 7, 2024, 11:25 | Blog
Jeff Sharman: Reflecting on the incredible progress made in lymphoma research
Jeff Sharman, Medical Director for Hematology Research at US Oncology, shared a post on LinkedIn,…
Oct 2, 2024, 15:25 | Blog
Can CAR T cell therapy be used to fight prostate cancer? - Cancer Research Institute
Cancer Research Institute shared a report by Charlie Schmidt on LinkedIn: "Can CAR T cell…
Sep 26, 2024, 17:47 | Insight
Charles Gaulin: Our initiative on enhancing advance care planning has received an ASCO Conquer Cancer Merit Award
Charles Gaulin shared a post on LinkedIn: "Excited to announce that our quality improvement initiative…
Sep 24, 2024, 12:50 | Dialogues
60 +1 Questions About Acute Lymphoblastic Leukemia in Children with Scott Howard
Professor Scott Howard is the Deputy Director at Yeolyan Hematology and Oncology Centerand the CEO…
Sep 14, 2024, 17:46 | Insight
Kai Rejeski: Second Primary Malignancies following CAR T-cell therapy
Kai Rejeski shared a post on X about a recent paper by Tobias Tix et…
Sep 5, 2024, 15:47 | Blog
Many Minds. One Focus - The Brain Cancer Centre
The Brain Cancer Centre made the following post on LinkedIn: "Awesome to see our Research Rockstar…
Sep 5, 2024, 05:09 | Blog
Joshua Brody: Excited for the CME event on CAR T-cell therapy for lymphoma and CLL at SOHO2024
Joshua Brody shared on LinkedIn: "Excited for the Amps-to-go-up-to-11 at tomorrow's CME event on CAR…
Aug 27, 2024, 21:34 | Insight
Shahrin Ahmed: Addressing weaknesses in invasive brain cancer by utilizing ROBO1 CAR T cells
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared a post on X: “Exploiting…
Aug 22, 2024, 13:58 | Blog
Rutgers Cancer Institute has treated its 200th patient with CAR T-cell therapy
Rutgers Cancer Institute shared on X:  “Rutgers Cancer Institute, the state’s only National Cancer Institute…
Aug 17, 2024, 19:47 | Blog
Marc Braunstein: Updates on CAR T-cell therapy in myeloma
Marc Braunstein, Associate Professor, Department of Medicine at NYU Grossman Long Island School of Medicine, shared…
Aug 16, 2024, 14:18 | Blog
Exploring CAR T-cell therapy and second cancers with Stephanie Goff on NCI's Cancer Currents blog - NCI Center for Cancer Research
NCI Center for Cancer Research shared on LinkedIn: "Cancer Currents: In this Q and A,…
Aug 14, 2024, 14:12 | Insight
ESHIMMUNE2024 starts in exactly one month
The ESH 3rd Translational Research Conference on Immune and Cellular Therapies: Focus on Advanced Gene-Engineered…
Aug 11, 2024, 11:41 | Insight
Hung Trinh: A rapid establishment for CAR T Cell Therapy Treatment Center Locator
Hung Trinh, Director of Process Development and MFG Science and Technology at Vyriad, posted on LinkedIn:…
Aug 10, 2024, 12:57 | Insight
MD Anderson Research Highlights
Featuring cell biology insights, new targets to prevent dysphagia, improved treatments for advanced cancers and…
Aug 4, 2024, 03:36 | Insight
Rahul Banerjee: Fascinating paper about time of day affecting CAR T-cell function
Rahul Banerjee, EASE (ECE Advocacy for Student Engagement) Director of Communications at Duke University Pratt…
Aug 3, 2024, 09:33 | Blog
Nonrelapse mortality after CAR T cell therapy by Dr. Kai Rejeski - IACH
The International Academy for Clinical Hematology shared a post on X: "Hear the latest at The…
Aug 1, 2024, 14:48 | Insight
Angela Mastronuzzi: The current landscape of CAR T-cell therapy for CNS tumors
Angela Mastronuzzi shared a post on LinkedIn about a recent paper titled "Chimeric antigen receptor…
Jul 30, 2024, 13:25 | Insight
David Fajgenbaum: Untold story of a drug initially approved for Castleman Disease that saved a young girl's life
David Fajgenbaum shared on X: "Did you know that a repurposed drug saved the most…
Jul 23, 2024, 07:41 | Blog
Tom Lynch: Fred Hutchinson Cancer Center expands immunotherapy offerings
Mazyar Shadman, Associate Professor of Medical Oncology at Fred Hutch Cancer Centre, shared a post…
Jul 21, 2024, 16:40 | Insight
Hung Trinh: FDA breakthrough designation for trial of cell-based therapy for high-risk lymphoma
Hung Trinh, Director of Process Development and MFG Science and Technology at Vyriad, posted on LinkedIn:…
Jul 18, 2024, 22:39 | Blog
Angela Mastronuzzi: GD2-Targeting therapy for GD2+ Medulloblastoma
Angela Mastronuzzi shared a post on LinkedIn: ''GD2-Targeting CAR T-cell Therapy for Patients with GD2+…
Jul 17, 2024, 14:06 | Opinion
ACGT awarded a $500,000 grant to Crystal Mackall to develop a CAR T-cell therapy
Alliance for Cancer Gene Therapy shared on X: "ACGT has awarded a $500,000 grant to…
Jul 12, 2024, 19:08 | Insight
Interesting study - A meta-analysis of nonrelapse mortality after CAR T cell therapy
Vivek Subbiah shared on X: "Interesting study published in NatureMedicine: A systematic review and meta-analysis…
Jul 9, 2024, 06:46 | Blog
David Cordas dos Santos: Nonrelapse mortality after CAR-T cell treatment
David Cordas dos Santos, PostDoc at Dana-Farber Cancer Institute, made the following post on X:…
Jul 8, 2024, 17:31 | Insight
Kai Rejeski: Underestimated aspect of CAR T-cell therapy: non-relapse mortality
Kai Rejeski, Visiting investigator at Memorial Sloan Kettering Cancer Center, shared on X: “Hot off…
Jul 7, 2024, 14:59 | Insight
Advancements in Oncology and Cancer Understanding - The Babak Lab
The Babak Lab made the following post on LinkedIn: "Weekly Digest Advancements in Oncology and Cancer…
Jul 6, 2024, 14:42 | Blog
Craig Bunnell has earned distinction as the inaugural Morse Family Chief Medical Officer - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute posted on LinkedIn: "After more than 15 years as a member of…
Jul 5, 2024, 14:45 | Insight
Maria Babak: Must read on CAR T-Cell Therapy
Maria Babak shared a post by The Babak Lab on LinkedIn: “This is a must-read…
Jun 24, 2024, 22:06 | Blog
Nausheen Ahmed: Approvals, toxicity and access updates on CART
Nausheen Ahmed, Medical Director of BMT Survivorship Program at The University of Kansas, shared a…
Jun 20, 2024, 07:48 | Blog
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
Vivek Subbiah shared a post on X: "Risk of Second Tumors and T-Cell Lymphoma after CAR…
Jun 18, 2024, 14:43 | Immune Oncology
CAR T Cell Therapy for Cancer Treatment
Introduction Chimeric antigen receptor - CAR T Cell therapy represents a groundbreaking approach in cancer…
Jun 14, 2024, 02:22 | Opinion
Harshal Chorya: Dr. Sam Yamshon captivating keynote on B-Cell Lymphomas
Harshal Chorya, HealthCare Professional at Baroda Medical College, shared a post on X: "Breakthrough Alert!…
Jun 13, 2024, 13:16 | Insight
Fabiana Perna: Our paper on novel toxicities of CAR T cell therapy
Fabiana Perna, Associate Member of Moffitt Cancer Center, shared on X: "Excited to share our paper…
May 31, 2024, 14:27 | Immune Oncology
How Does Immunotherapy Work
What is immunotherapy? Immunotherapy is a type of cancer treatment that uses the power of…
May 30, 2024, 16:14 | Blog
Alexander González: The challenges of CARNK existing in the process from lab production to tumor infiltration
Alexander González, Internal Clinician at 3cert Limited, shared on LinkedIn: “The challenges of CARNK existing…
May 28, 2024, 14:06 | Insight
Myeloma Paper of the Day, May 28th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Retrospective Memorial Sloan Kettering study suggests…
May 22, 2024, 13:51 | Blog
Gaurav Narula: Great two days brainstorming to help formulate the research questions for CAR T cell therapy
Gaurav Narula, Medical Oncologist at Postgraduate Institute of Medical Education and Research, Chandigarh, shared a…
May 21, 2024, 15:48 | Blog
Cancer Network - A panel of experts on multiple myeloma discuss the rationale for CAR T-cell therapy
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by Cancer Network, on X: "So much fun…
May 21, 2024, 15:16 | Blog
A panel of experts on multiple myeloma discuss the rationale for CAR T-cell therapy - Cancer Network
Cancer Network shared a post on X: "A panel of experts on multiple myeloma discuss…
May 16, 2024, 15:09 | Insight
Myeloma Paper of the Day, May 16th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: DESCAR-T registry of French patients…
May 15, 2024, 10:54 | Dialogues
Oncothon: Challenges And Successes In Pediatric Hematology and Oncology
Oncothon is a telethon spanning 24 hours, dedicated to gathering donations for childhood cancer research.…
May 8, 2024, 13:50 | Opinion
NCI Center for Cancer Research - Alka Dwivedi was honored in this year's list of TIME100 Most Influential in Health
NCI Center for Cancer Research shared a post on LinkedIn: "IN THE NEWS: If you haven't…
May 3, 2024, 23:43 | Blog
Tanja Obradovic: All eyes are on ADCs coming from China's biotech innovation engine and CAR-T cell therapy
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON plc., shared a post on…
May 1, 2024, 10:09 | Blog
Amanda Impellizzeri: Thank you for making the West Virginia Oncology Society Spring Conference a success
Amanda Impellizzeri, Executive Director at Louisiana Oncology Society, posted on LinkedIn: "Thank you to all the…
Apr 28, 2024, 23:40 | Blog
Susanna Greer: Boosting the CAR T party
Susanna Greer, Chief Scientific Officer at the V Foundation for Cancer Research, published the following…
Apr 20, 2024, 18:05 | Insight
Nicolas Hubacz: T Cell Vs Cancer Cell
Nicolas Hubacz, Research Products Business Development Manager at Magstim, shared a post on LinkedIn: "CAR…
Apr 20, 2024, 17:31 | Blog
The U.S. FDA recently approved two CAR T-cell therapies for earlier treatment of adults with multiple myeloma - The Leukemia and Lymphoma Society
The Leukemia and Lymphoma Society shared a post on LinkedIn: "PROGRESS! The U.S. FDA recently approved…
Apr 16, 2024, 01:52 | Insight,Opinion
Angela Mastronuzzi: We investigated whether CAR T-cells directed towards the disialoganglioside GD2 can represent a potentially more effective treatment with reduced long-term side effects
Apr 15, 2024, 16:17 | Blog
Selwyn M. Vickers: MSK hosted a screening of the documentary Living Drugs
Selwyn M. Vickers, President and CEO at Memorial Sloan Kettering Cancer Center shared on X:…
12
All: 125 Posts: 1 - 100
Special Coverage